Insiders trading at Miragen Therapeutics Inc
Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth a Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.
What does Miragen Therapeutics Inc's logo look like?
Miragen Therapeutics Inc executives and stock owners
Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Diana Escolar,
Chief Medical Officer -
Jason Leverone,
Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary -
Jeffrey Hatfield,
Independent Chairman of the Board -
Joseph Turner,
Independent Director -
Arlene Morris,
Independent Director -
Christopher Bowden,
Independent Director -
Tomas Kiselak,
Director -
Peter Harwin,
Director -
Lee Rauch,
Chief Executive Officer, Director -
Jonathan Violin,
President, Chief Operating Officer -
Bruce Booth,
Director -
Kyle Lefkoff,
Director -
Paul D Rubin,
EVP, Research & Development -
Adam Scott Levy,
Chief Business Officer -
Thomas E. Hughes,
Director -
Bennett S Lebow,
Director -
Global Master Fund Lp Logos,
10% owner -
John W Creecy,
Director -
Kevin Koch,
Director -
Funds Management Llc Fairmo...,
-
William Stuart Marshall,